Literature DB >> 17306383

CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways.

Marc J Berna1, K Martin Hoffmann, Jose A Tapia, Michelle Thill, Andrea Pace, Samuel A Mantey, Robert T Jensen.   

Abstract

Protein kinase D1 (PKD1) is involved in cellular processes including protein secretion, proliferation and apoptosis. Studies suggest PKD1 is activated by various stimulants including gastrointestinal (GI) hormones/neurotransmitters and growth factors in a protein kinase C (PKC)-dependent pathway. However, little is known about the mechanisms of PKD1 activation in physiologic GI tissues. We explored PKD1 activation by GI hormones/neurotransmitters and growth factors and the mediators involved in rat pancreatic acini. Only hormones/neurotransmitters activating phospholipase C caused PKD1 phosphorylation (S916, S744/748). CCK activated PKD1 and caused a time- and dose-dependent increase in serine phosphorylation by activation of high- and low-affinity CCK(A) receptor states. Inhibition of CCK-stimulated increases in phospholipase C, PKC activity or intracellular calcium decreased PKD1 S916 phosphorylation by 56%, 62% and 96%, respectively. PKC inhibitors GF109203X/Go6976/Go6983/PKC-zeta pseudosubstrate caused a 62/43/49/0% inhibition of PKD1 S916 phosphorylation and an 87/13/82/0% inhibition of PKD1 S744/748 phosphorylation. Expression of dominant negative PKC-delta, but not PKC-epsilon, or treatment with PKC-delta translocation inhibitor caused marked inhibition of PKD phosphorylation. Inhibition of Src/PI3K/MAPK/tyrosine phosphorylation had no effect. In unstimulated cells, PKD1 was mostly located in the cytoplasm. CCK stimulated translocation of total and phosphorylated PKD1 to the membrane. These results demonstrate that CCK(A) receptor activation leads to PKD activation by signaling through PKC-dependent and PKC-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17306383      PMCID: PMC1924924          DOI: 10.1016/j.bbamcr.2006.12.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  70 in total

Review 1.  Protein kinase D signaling.

Authors:  Enrique Rozengurt; Osvaldo Rey; Richard T Waldron
Journal:  J Biol Chem       Date:  2005-02-08       Impact factor: 5.157

2.  BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways.

Authors:  Ayse B Celil; Phil G Campbell
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

3.  Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu.

Authors:  S A Matthews; E Rozengurt; D Cantrell
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

4.  Angiotensin II-induced protein kinase D activation is regulated by protein kinase Cdelta and mediated via the angiotensin II type 1 receptor in vascular smooth muscle cells.

Authors:  Mingqi Tan; Xuemin Xu; Motoi Ohba; Mei-Zhen Cui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-21       Impact factor: 8.311

5.  Oxidative stress induces protein kinase C-mediated activation loop phosphorylation and nuclear redistribution of protein kinase D.

Authors:  Richard T Waldron; Osvaldo Rey; Elena Zhukova; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

6.  Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation.

Authors:  Jérome Lemonnier; Chafik Ghayor; Jérome Guicheux; Joseph Caverzasio
Journal:  J Biol Chem       Date:  2003-10-22       Impact factor: 5.157

7.  Lipid raft disruption triggers protein kinase C and Src-dependent protein kinase D activation and Kidins220 phosphorylation in neuronal cells.

Authors:  Noemí Cabrera-Poch; Lucía Sánchez-Ruiloba; María Rodríguez-Martínez; Teresa Iglesias
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

8.  Protein kinase D potentiates DNA synthesis induced by Gq-coupled receptors by increasing the duration of ERK signaling in swiss 3T3 cells.

Authors:  James Sinnett-Smith; Elena Zhukova; Nena Hsieh; Xiaohua Jiang; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2004-02-12       Impact factor: 5.157

9.  PKC-alpha regulates cardiac contractility and propensity toward heart failure.

Authors:  Julian C Braz; Kimberly Gregory; Anand Pathak; Wen Zhao; Bogachan Sahin; Raisa Klevitsky; Thomas F Kimball; John N Lorenz; Angus C Nairn; Stephen B Liggett; Ilona Bodi; Su Wang; Arnold Schwartz; Edward G Lakatta; Anna A DePaoli-Roach; Jeffrey Robbins; Timothy E Hewett; James A Bibb; Margaret V Westfall; Evangelia G Kranias; Jeffery D Molkentin
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

10.  Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.

Authors:  Peter Storz; Heike Döppler; Alex Toker
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

View more
  36 in total

1.  Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.

Authors:  Veronica Sancho; Terry W Moody; Samuel A Mantey; Alessia Di Florio; Hirotsugu Uehara; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2010-05-12       Impact factor: 3.750

2.  Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells.

Authors:  Hatim A Hassan; Ming Cheng; Peter S Aronson
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

3.  FGF21 Is an Exocrine Pancreas Secretagogue.

Authors:  Katie C Coate; Genaro Hernandez; Curtis A Thorne; Shengyi Sun; Thao D V Le; Kevin Vale; Steven A Kliewer; David J Mangelsdorf
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

4.  The Src kinase Yes is activated in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters, but not pancreatic growth factors, which stimulate its association with numerous other signaling molecules.

Authors:  Veronica Sancho; Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2012-05-19

5.  The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.

Authors:  Bernardo Nuche-Berenguer; Irene Ramos-Álvarez; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2016-02-18

6.  PKCθ activation in pancreatic acinar cells by gastrointestinal hormones/neurotransmitters and growth factors is needed for stimulation of numerous important cellular signaling cascades.

Authors:  Veronica Sancho; Marc J Berna; Michelle Thill; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2011-07-23

Review 7.  Protein kinase D enzymes: novel kinase targets in pancreatic cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 3.869

Review 8.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 9.  Bombesin receptor subtype 3 as a potential target for obesity and diabetes.

Authors:  Nieves González; Paola Moreno; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2015-06-12       Impact factor: 6.902

10.  The novel protein kinase C isoforms -delta and -epsilon modulate caerulein-induced zymogen activation in pancreatic acinar cells.

Authors:  Edwin C Thrower; Sara Osgood; Christine A Shugrue; Thomas R Kolodecik; Anamika M Chaudhuri; Joseph R Reeve; Stephen J Pandol; Fred S Gorelick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.